(redirected from Epidermal growth factor)
Also found in: Dictionary, Medical, Legal, Financial, Acronyms, Encyclopedia, Wikipedia.
Graphic Thesaurus  🔍
Display ON
Animation ON
  • adj

Synonyms for epidermal

of or relating to a cuticle or cuticula

References in periodicals archive ?
The results indicate that the interactions between estrogen, progesterone and epidermal growth factor receptor pathways may be considered relevant targets for the treatment of hormone-dependent breast cancers," she said.
examines applications of Epidermal Growth Factor, its consumers
professor of clinical medicine and chief of the section on gastrointestinal oncology, University of California, San Francisco, said the results may validate epidermal growth factor as a target for pancreatic cancer and "certainly gives us clues for subsequent studies that might capitalize on this" mechanism for new treatments.
Increased 12-1ipogense expression in breast cancer tissues and cells: regulation by epidermal growth factor.
People who were more lonely and depressed exhibited significantly lower epidermal growth factor levels, compared with people who were not particularly lonely or depressed.
Danilenko et al investigated recombinant epidermal growth factor, keratinocyte growth factor, platelet-derived growth factor-BB, and neu differentiation factor.
OTCBB:RBCL), announced the initiation of human clinical trials, in three medical institutions, designed to evaluate the efficacy of its topical wound gel, Regenecare[TM], in the relief of painful, itching skin rashes that occur as a side effect during treatment by a group of widely-used cancer drugs known as epidermal growth factor receptor (EGFR) inhibitors.
A human epidermal growth factor receptor type 1/epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor as a single agent treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), who have failed at least one prior chemotherapy regimen.
The researchers concentrate on a drug that blocks a mutated form of the epidermal growth factor (EGF) receptor, which may benefit 5 percent of lung cancer patients.
Because treatment by tumor promoters [12-O-tetradecanoylphorbol-13-acetate (TPA), epidermal growth factor (EGF), or tumor necrosis factor alpha (TNF[alpha])] transforms clone 41 cells to anchorage-independent and tumorigenic phenotypes, they are considered to be undergoing late-stage tumor promotion.
Hana Biosciences (NASDAQ:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced that it has acquired exclusive rights to develop and commercialize Menadione, a preclinical product candidate for the prevention and treatment of skin rash associated with the use of epidermal growth factor receptor (EGFR) inhibitors in New York.
EGFR encodes a molecule that acts as a docking station on cell surfaces for a protein called epidermal growth factor (EGF).
Full browser ?